Science

16-year-old Ethan Yan wins $50,000 scholarship to develop affordable AI system to detect leukemia cells |

16-year-old Ethan Yan has developed an affordable artificial intelligence system that helps clinics diagnose acute myeloid leukemia in bone marrow samples. His project, ‘Yabela’, works as a microscope plugin, allowing medical professionals to see abnormal cells without relying on expensive scans of whole slides. The system identifies key regions in the sample and counts abnormal cells on standard glass slides, making it easily accessible to clinics with limited pathology services. Testing with real patient samples showed that ‘Yabela’ achieved expert-level accuracy in identifying leukemia cells, with a setup cost of about $100. The project earned Yan a $50,000 scholarship as a 2025 Davidson Fellow, according to the Davidson Institute.

How Ethan Yan developed an affordable AI system to identify leukemia cells

Ethan Yan, a student at Groton School in Massachusetts, was 16 years old when he was named a 2025 Davidson Fellow and was awarded a $50,000 scholarship by the Davidson Institute. His project, titled ‘Abela: A Low-Cost Automatic Artificial Intelligence System for the Real-Time Localization and Classification of Acute Myeloid Leukemia in Bone Marrow Smears’, reflects his interest in computer technology and its potential to address healthcare challenges.Yan said, “I have been inspired by the work, commitment, and impact of many previous Davidson Fellows and am very excited to join and connect with this community of innovators. For me, being named a Davidson Fellow is not only recognition of the work I have done but also a meaningful confirmation that the efforts of young researchers have the potential to make a tangible impact on society.”

U-Ethan Yan uthuthukise kanjani uhlelo lwe-AI oluthengekayo lokuhlonza amangqamuzana egazi leukemia<br />” msid=”134893208″ imgsize=”145023″ resizemode=”4″ width=”” title=”PC: Davidson Institute” placeholdersrc=”https://static.toiimg.com/photo/83033472.cms” offsetvertical=”0″ placeholdermsid=”47529300″ type=”thumb” class=”” src=”https://static.toiimg.com/photo/imgsize-145023,msid-134893208/how-ethan-yan-developed-an-affordable-ai-system-to-identify-leukaemia-cellsbr.jpg” data-api-prerender=”true”/></p>
<p>PC: The Davidson Institute</p>
</div>
</div>
<p><span class=

‘Allocate’ uses artificial intelligence to analyze bone marrow samples

Leukemia diagnosis often relies on expensive equipment and specialist analyses, making timely diagnosis a challenge in resource-limited settings. Yan developed ‘Allocate’ to address this gap by using an artificial intelligence plugin with artificial intelligence capabilities. The system identifies key regions and counts abnormal cells directly on standard glass slides, without requiring large or expensive scans of whole slides.It works with existing microscopes and has a setup cost of about $100. Tests using real patient samples showed that ‘Yabela’ achieved expert-level accuracy in identifying leukemia cells. By combining deep learning with affordable materials, he aims to make early detection more accessible to clinics around the world, especially those without access to specialized disease services.

How a family experience inspired Yan to work on leukemia diagnosis

Yan’s inspiration for the project came from a personal experience. Her aunt was diagnosed with acute myeloid leukemia a few years ago, and she said the family found the diagnosis frustrating because it involved complicated steps and it took a long time before she received treatment. Acute leukemia involves the uncontrolled growth of immature white blood cells, known as blasts, in the bone marrow.Delay in treatment can make this disease fatal especially because it interferes with the production of vital blood cells. This can lead to serious complications, including infections and bleeding. His aunt’s experience inspired him to create a system that could support rapid and accessible testing, especially in underserved settings.

‘Yabela’ is designed for areas where there are no pathologists

Yan began distributing ‘Allocate’ to several local hospitals during the summer, where he learned how limited access to pathology services can delay diagnosis. One doctor told him that a doctor from their hospital traveled to Congo every six months to collect patient slides and send them back to him for remote analysis. With no pathologist in the area, samples pile up, and patients often wait months.Yan said many had died or had reached a stage where treatment was no longer available by the time their results came in, as acute leukemia can progress quickly. ‘Allocate’ is designed to support pre-screening and remote pathology review in such settings. It processes the samples and sends the results, along with the actual patient data, to the pathologist for evaluation, even if there is no specialist available on site.


Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button